Medicare Enrolled

Dr. Ebenezer Appah, M.D.

Hematology & Oncology · Abilene, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2000 PINE ST, Abilene, TX 79601
3256706340
In practice since 2013 (12 years)
NPI: 1730525213 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Appah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Appah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Appah

Dr. Ebenezer Appah is a hematology & oncology in Abilene, TX, with 12 years in practice. Based on federal Medicare data, Dr. Appah performed 1,265 Medicare services across 662 unique beneficiaries.

Between the years covered by Open Payments, Dr. Appah received a total of $5,414 from 60 pharmaceutical and/or device companies across 290 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Appah is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice▲ Top 46% volume in TX$ $5,414 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,265
Medicare services
Top 46% in TX for hematology & oncology
662
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~105 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Blood draw (venipuncture)395$8$8
Office visit, established patient (30-39 min)335$85$365
Office visit, established patient, complex (40-54 min)204$130$510
Office visit, established patient (20-29 min)92$59$257
Hospital follow-up visit, moderate complexity73$58$227
Initial hospital admission, high complexity52$133$500
Hospital follow-up visit, high complexity46$91$341
New patient office visit, complex (60-74 min)35$163$626
New patient office visit (45-59 min)21$119$489
Initial hospital admission, moderate complexity12$86$380
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,414
Total received (2018-2024)
Avg $773/year across 7 years
Top 42% in TX for hematology & oncology
60
Companies
290
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,518 (83.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$896 (16.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$484
2023
$688
2022
$376
2021
$138
2020
$316
2019
$1,567
2018
$1,846

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$516
Astellas Pharma US Inc
$489
E.R. Squibb & Sons, L.L.C.
$484
Novartis Pharmaceuticals Corporation
$378
Janssen Biotech, Inc.
$296
Lilly USA, LLC
$284
Amgen Inc.
$217
Celgene Corporation
$201
Incyte Corporation
$197
Merck Sharp & Dohme Corporation
$193
Alexion Pharmaceuticals, Inc.
$172
AstraZeneca Pharmaceuticals LP
$152
INSYS Therapeutics Inc
$138
Merck Sharp & Dohme LLC
$108
Bayer HealthCare Pharmaceuticals Inc.
$106
AbbVie, Inc.
$100
Agios Pharmaceuticals, Inc.
$86
JAZZ PHARMACEUTICALS INC.
$83
Eisai Inc.
$80
TESARO, Inc.
$72
BTG International, Inc.
$68
Exelixis Inc.
$63
Rigel Pharmaceuticals, Inc.
$48
Coherus Biosciences Inc.
$42
Stemline Therapeutics Inc.
$40
Seagen Inc.
$37
Karyopharm Therapeutics Inc.
$36
Daiichi Sankyo Inc.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
PharmaEssentia USA Corporation
$33
Shire North American Group Inc
$30
Janssen Pharmaceuticals, Inc
$30
EISAI INC.
$30
GENZYME CORPORATION
$29
Genentech USA, Inc.
$28
Collegium Pharmaceutical, Inc.
$27
Deciphera Pharmaceuticals Inc.
$27
Pharmacyclics LLC, An AbbVie Company
$26
Lexicon Pharmaceuticals, Inc.
$26
Takeda Pharmaceuticals U.S.A., Inc.
$26
AMAG Pharmaceuticals, Inc.
$24
Kyowa Kirin, Inc.
$23
EMD Serono, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$21
Genmab U.S., Inc.
$20
Ipsen Biopharmaceuticals, Inc
$19
TerSera Therapeutics LLC
$19
Regeneron Healthcare Solutions, Inc.
$17
AbbVie Inc.
$17
Pharmacyclics LLC, an AbbVie Company
$17
TAIHO ONCOLOGY, INC.
$17
Adaptive Biotechnologies Corporation
$16
Jazz Pharmaceuticals Inc.
$16
Dendreon Pharmaceuticals LLC
$16
NOVARTIS PHARMACEUTICALS CORPORATION
$16
PUMA BIOTECHNOLOGY, INC.
$16
Puma Biotechnology, Inc.
$15
Seattle Genetics, Inc.
$14
Clovis Oncology, Inc.
$12
Spectrum Pharmaceuticals Inc.
$11
Top 3 companies account for 27.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Aliqopa · Aranesp · BESREMI · BOSULIF · BRAFTOVI · Bavencio · Blincyto · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · DARZALEX · ELIQUIS · ELREXFIO · ELZONRIS · EMPLICITI · ERLEADA · Enhertu · Erleada · FERAHEME · Folotyn · GILOTRIF · Halaven · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MVASI · MYLOTARG · NERLYNX · NINLARO · NOXAFIL · Nerlynx · Neulasta · Nplate · Nubeqa · OPDIVO · ORGOVYX · Orserdu · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pomalyst · QINLOCK · REBLOZYL · RYDAPT · Revlimid · Rezlidhia · Rubraca · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNDROS · Stivarga · TAGRISSO · TASIGNA · TECVAYLI · TIBSOVO · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tivdak · ULTOMIRIS · Udenyca · VARUBI · VENCLEXTA · VONVENDI · VORAXAZE · VYXEOS · Venclexta · Vitrakvi · XALKORI · XARELTO · XOSPATA · XPOVIO · XTAMPZA · XTAMPZAER · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $428 per 100 Medicare services performed
Looking for a hematology & oncology in Abilene?
Compare hematology & oncologys in the Abilene area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
5
Per 100K population
25.0
County median income
$63,472
Nearest hospital
HENDRICK MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Appah is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Appah experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Appah performed 395 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Appah receive payments from pharmaceutical companies?
Yes. Dr. Appah received a total of $5,414 from 60 companies across 290 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Appah's costs compare to other hematology & oncologys in Abilene?
Dr. Appah's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Appah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →